Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancer

Tomer Meirson; Daniel A. Goldstein; Bishal Gyawali; Ian F. Tannock

doi:10.1016/S1470-2045(23)00165-1

Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancer

Tomer Meirson, Daniel A. Goldstein, Bishal Gyawali, Ian F. Tannock

Research output: Contribution to journal › Comment/debate

9 Scopus citations

Original language	English
Pages (from-to)	589-593
Number of pages	5
Journal	The Lancet Oncology
Volume	24
Issue number	6
DOIs	https://doi.org/10.1016/S1470-2045(23)00165-1
State	Published - Jun 2023
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1470-2045(23)00165-1

Cite this

@article{c9f853f2b18e4f03905906d3d0ab1071,

title = "Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancer",

author = "Tomer Meirson and Goldstein, {Daniel A.} and Bishal Gyawali and Tannock, {Ian F.}",

year = "2023",

month = jun,

doi = "10.1016/S1470-2045(23)00165-1",

language = "אנגלית",

volume = "24",

pages = "589--593",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "6",

}

TY - JOUR

T1 - Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancer

AU - Meirson, Tomer

AU - Goldstein, Daniel A.

AU - Gyawali, Bishal

AU - Tannock, Ian F.

PY - 2023/6

Y1 - 2023/6

UR - http://www.scopus.com/inward/record.url?scp=85160415752&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(23)00165-1

DO - 10.1016/S1470-2045(23)00165-1

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 37146621

AN - SCOPUS:85160415752

SN - 1470-2045

VL - 24

SP - 589

EP - 593

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 6

ER -

Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancer

UN SDGs

Access to Document

Other files and links

Cite this